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Metabolomic fingerprinting of bodily fluids can reveal the underlying causes of metabolic
disorders associated with many diseases, and has thus been recognized as a potential tool for
disease diagnosis and prognosis following therapy. Here we report a rapid approach in which
direct analysis in real time (DART) coupled with time-of-flight (TOF) mass spectrometry (MS)
and hybrid quadrupole TOF (Q-TOF) MS is used as a means for metabolomic fingerprinting
of human serum. In this approach, serum samples are first treated to precipitate proteins, and
the volatility of the remaining metabolites increased by derivatization, followed by DART MS
analysis. Maximum DART MS performance was obtained by optimizing instrumental param-
eters such as ionizing gas temperature and flow rate for the analysis of identical aliquots of a
healthy human serum samples. These variables were observed to have a significant effect on
the overall mass range of the metabolites detected as well as the signal-to-noise ratios in DART
mass spectra. Each DART run requires only 1.2 min, during which more than 1500 different
spectral features are observed in a time-dependent fashion. A repeatability of 4.1% to 4.5% was
obtained for the total ion signal using a manual sampling arm. With the appealing features of
high-throughput, lack of memory effects, and simplicity, DART MS has shown potential to
become an invaluable tool for metabolomic fingerprinting. (J Am Soc Mass Spectrom 2010,
21, 68–75) © 2010 American Society for Mass SpectrometryMetabolomic fingerprinting, an unbiased, globalscreening approach to classify samples based onmetabolite patterns or “fingerprints”, has been
performed in a wide variety of biological sample types
such as urine, plasma, serum, and tissues [1]. Nuclear
magnetic resonance (NMR) and mass spectrometry are
two widely used analytical platforms applied to metabo-
lomic fingerprinting. NMR has the advantage of requiring
little sample preparation, and of producing datasets that
are more easily mined [2–4], but cost and sensitivity are
two of its major limitations. Gas chromatography-mass
spectrometry (GC-MS) and liquid chromatography-mass
spectrometry (LC-MS) are two additional techniques com-
monly used in metabolomic workflows [1, 5–9]. Despite
being extremely comprehensive, GC-MS and LC-MS suf-
fer from low analysis throughput and memory effects of
the chromatographic supports, particularly when investi-
gating metabolites in biological matrices such as serum.
To overcome the above described limitations, enabling
technologies for the effective analysis of metabolomes are
still rapidly evolving.
Direct analysis in real time (DART) is a plasma-based
ion generation technique that operates under ambient
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doi:10.1016/j.jasms.2009.09.004conditions. It belongs to a wider family of ambient
plasma ionization techniques that includes direct atmo-
spheric pressure photo-ionization (DAPPI) [10], direct
analysis in real time (DART) [11], flowing atmospheric
pressure afterglow (FAPA) [12], plasma-assisted de-
sorption ionization (PADI) [13], desorption atmospheric
pressure photoionization (DAPCI) [14], low-temperature
plasma (LTP) ionization [15], and dielectric barrier
discharge ionization (DBDI) [16]. DART enables ioniza-
tion in a noncontact fashion with minimal memory
effects. Samples are handled either manually or with
the assistance of autosamplers, and mainly high purity
compressed gases (He or N2) are required as consum-
ables resulting in low cost per sample [11]. DART
operates by first creating a glow discharge within a
flowing stream of gas (N2 or He) to form metastables
that interact with water in the atmosphere to produce
protonated water clusters. These clusters react by pro-
ton transfer with analytes desorbed by the heated gas
stream. In most cases, immediate ionization can be
achieved with no sample preparation. DART has been
successfully applied to the analysis of pharmaceuticals
[17, 18], counterfeit drugs [19], bacterial fatty acid
methyl esters [20], flavors and fragrances [21], and
several other interesting applications [22, 23].
In this work, we report a method for the rapid
metabolomic fingerprinting of human serum via
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various experimental parameters is discussed, and the
identification of metabolites in serum is demonstrated
using accurate mass measurements and spiking exper-
iments. To the best of our knowledge, this is the first
report on the coupling of a DART ion source to a hybrid
Q-TOF mass spectrometer, and on the use of DART for
serum metabolomics.
Experimental
Samples and Reagents
N-trimethylsilyl-N-methyltrifluoroacetamide (MSTFA)
and trimethylchlorosilane (TMCS) were obtained from
Alfa Aesar (Ward Hill, MA, USA), anhydrous pyridine,
acetonitrile (ACN), acetone, and isopropanol were from
EMD Chemicals (Gibbstown, NJ, USA), polyethylene
glycol standard 400 and 600 (PEG 400, 600) were from
Fluka Chemical Corp. (Milwaukee, WI, USA), healthy
human serum (S7023–50 mL), creatinine, urea, cysteam-
ine, triethylamine, L-proline, L-alanine, L-arginine, L-
serine, and L-lysine were purchased from Sigma-Aldrich
Corp. (St. Louis, MO, USA), pyroglutamic acid was
from AnaSpec (San Jose, CA, USA), 3-indolebutyric acid
was from TCI America (Wellesley Hills, MA, USA), and
helium (99.999% purity) was purchased from Airgas,
Inc. (Atlanta, GA, USA).
Mass Spectrometry
Serum metabolomic analysis was performed in positive
ion mode via a DART ion source (IonSense, Saugus,
MA, USA) coupled to (1) an orthogonal time-of-flight
(TOF) mass spectrometer (JEOL AccuTOF; Tokyo, Japan)
and (2) a Q-TOF mass spectrometer (Bruker micr-
OTOF-Q I; Bremen, Germany). The Q-TOF mass spec-
trometer interface was modified before coupling to
DART by adding to its front end a custom made
VAPUR gas-ion separator tube (IonSense, Saugus, MA,
USA). This VAPUR interface was itself connected to an
Edwards E2M2 roughing pump (Edwards, Westmin-
ster, MD, USA) to remove the excess discharge gas
flowing into the mass spectrometer inlet. The AccuTOF
TOF mass spectrometer was interfaced to the DART ion
source directly through a small orifice (375 m diam-
eter) interface. In both cases, derivatized serum samples
were placed within the ionization region using a home-
built sampling arm which secured Dip-it tips (IonSense,
Saugus, MA, USA) at a fixed 3 mm distance from the
ion source gas exit. Before DART MS analysis, 0.5 L of
derivatized serum solution was pipette-deposited onto
the glass end of the Dip-tip coupled to the sampling
arm, a 1.2 min data acquisition run started, and the
sample allowed to air dry for 0.65 min. The sampling
arm was then rapidly switched so that the dried sample
was exposed to the ionizing zone of the DART ion
source. After 0.9 min in the acquisition run (0.25 min
sampling time), the sample was removed, and a newDip-it placed on the sample holder, while the remaining
0.3 min of the run was completed.
DART ion source helium flow rates of 3.0 L min1
and 0.55 L min1 heated to 200 °C were chosen for TOF
and Q-TOF experiments, respectively. The glass tip-end
was positioned 1.5 mm below the mass spectrometer
inlet for TOF experiments and at the center of the
ceramic tube inlet for Q-TOF experiments. A discharge
needle voltage of 3600 V, perforated electrode voltage
of150 V, and grid electrode voltages of250 V (TOF),
and50 V (Q-TOF) were chosen, respectively. Accurate
mass spectra were acquired in the m/z 60–1000 range
with a spectral recording interval of 1.0 s. For TOF
experiments, the RF ion guide peak voltage was set to
1200 V to enable ion transmission of a wide range of
species present in serum. The remaining settings for the
TOF mass spectrometer were as follows: ring lens, 8
V, orifice 1,40 V, orifice 2,6 V, orifice 1 temperature,
80 °C, and detector voltage, 2800 V. TOF mass drift
compensation was performed after analysis of each
sample using a 0.20 mM PEG 600 standard in methanol.
The measured resolving power of the TOF mass spec-
trometer was 6000 at FWHM, with observed mass
accuracies in the range 2–20 ppm, depending on the
signal-to-noise ratio (S/N) of the particular peak under
investigation.
The settings for the Q-TOF mass spectrometer were
as follows: capillary voltage, 1500 V, end plate offset,
500 V, drying gas flow, 2.0 L min1, drying gas
temperature, 150 °C. The minimummeasured resolving
power of the Q-TOF mass spectrometer was 14,500 at
FWHM form/z 415.25, with observed mass accuracies in
the range 0.6–2.0 ppm. The instrument was mass cali-
brated before performing experiments using a custom
mixture of trimethylamine, PEG 400, and 600 in meth-
anol (1:2:2:1200 vol/vol), and all mass spectra were
centroided in real time.
Metabolites were tentatively identified by matching
accurate masses against a custom built database con-
taining 2924 entries corresponding to unique endoge-
nous human metabolites found in the Human Metabo-
lome Database (HMDB, www.hmdb.ca). Each entry
was manually expanded to take into account the mono-,
di-, and/or tri-trimethylsilane (TMS) derivatives. En-
tries for families of compounds not reacting with the
MSTFA/TMCS reagent mixture were not expanded.
Matching of database accurate mass records to experi-
mental data were performed using the SearchFromList
application included in the Mass Spec Tools suite of
programs (ChemSW, Fairfield, CA, USA) using a toler-
ance of 5 m and a relative intensity cutoff of 5%.
Sample Preparation
Upon removal from a 80 °C freezer, serum samples
were immediately thawed on ice. Two-hundred L
serum aliquots were pipetted and mixed with 1 mL of
freshly-prepared, chilled (8 °C) and degassed 2:1
(vol/vol) acetone:isopropanol mixture. The mixture
70 ZHOU ET AL. J Am Soc Mass Spectrom 2010, 21, 68–75was vortexed and placed in a second freezer at 18 °C
overnight to precipitate proteins, followed by centrifu-
gation at 13,000 g for 5 min. The supernatant was
transferred to a clean centrifuge tube, and the solvent
was evaporated in a speed vacuum concentrator to
complete dryness for 24 h. The solid residue was then
re-dissolved in 25 L anhydrous pyridine, and shaken
for 1 h at room temperature for complete dissolution.
Fifty L of MSTFA containing 0.1% TMCS were added
to the sample in a N2-purged glove box. The mixture
was incubated at 50 °C in an inert N2 atmosphere for 30
min, resulting in derivatization of amide, amine, and
hydroxyl groups. The supernatant of this derivatized
mixturewas subject to DARTmass spectrometric analysis.
Results and Discussion
General Spectral Appearance
DART-TOF mass spectra for nonderivatized human
serum following protein precipitation and for an iden-
tical sample derivatized with MSTFA/TMCS are shown
in Figure 1. Only about 100 total signals were obtained
Figure 1. Background-corrected DART-TOF ma
range: (a) nonderivatized serum sample, (b) d
mixture (identity of ions follow number betwee
S-1), and (d) derivatized serum sample spiked
observed in (b) are given in Table S-1.from nonderivatized serum (Figure 1a), while more
than 1500 detectable signals were observed in derivat-
ized serum (Figure 1b). Underivatized serum presented
signals mainly in the m/z 100–300 mass range, whereas
for derivatized serum signals up to m/z 800 were
detected due to the enhanced volatility of the TMSmetab-
olite derivatives. Increased volatility facilitates thermal
desorption before chemical ionization within the region
between the DART ion source exit and themass spectrom-
eter inlet. Overall signal intensity was increased on aver-
age by a factor of 5 following derivatization.
Peaks with relative abundance higher than 5% of the
base peak in Figure 1b were identified based on an
analysis of the number of TMS groups incorporated
upon derivatization and accurate mass matching of the
corresponding species against the custom built metab-
olite database. HMDB entries matched following this
procedure are listed in Supplemental Material Table
S-1, which can be found in the electronic version of this
article. Twenty-five unknowns were identified. Confir-
mation of the identity of 10 of these metabolites was
performed by spiking the serum sample with a mixture
ectra of healthy human serum in the 60–800m/z
tized serum sample, (c) derivatized standards
enthesis on second column from right in Table
standards. Tentative identities of metabolitesss sp
eriva
n par
with
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identical methods (Figure 1d). The standards spiked are
listed with numbers between parentheses on the second
column from right in Table S-1 and labeled in Figure 1d.
Upon spiking, the intensity of the corresponding signals
in Figure 1b increased, thus confirming the ability of
this approach to detect and identify metabolites in
human serum. For redundancy and further validation,
the identity of the ionic species observed for the previ-
ous standards in the absence of biological matrix was
also checked by spiking a solvent and derivatization
reactant mixture blank (Figure 1c). Ion adducts such as
[M  H], [M  TMS  H], [M  2TMS  H], and
[M 3TMSH]were observed. These are noted with
asterisks in Table S-1. These experiments reinforced the
idea that analysis of TMS derivatized metabolites is
preferable to the direct analysis of their more hydro-
philic underivatized counterparts, despite the need for
additional sample preparation steps. Intermolecular hy-
drogen bonding interactions in underivatized metabo-
lite mixtures are strong, and result in decreased volatil-
ity. Derivatization replaces reactive hydrogen atoms in
acidic and basic groups by TMS, leading to a reduction
in mixture polarity.
Effect of Helium Gas Flow Rate and Temperature
Helium gas temperature and flow rate are two major
parameters affecting DART ion transmission [24].
DART-TOF spectra for various helium gas tempera-
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Figure 2. Effect of helium gas temperature on
of derivatized serum: (a) background corrected
number of metabolites matched to HMDB databa
signals at m/z 205.12, 467.22, and 762.25 versus heliutures and the corresponding number of metabolites
identified by accurate mass matching are shown in
Figure 2a and b, respectively. As temperature was
increased, the number of metabolites found was also
observed to increase up to 200 °C. It is important to note
that temperature values refer to set values in the soft-
ware, but that the local temperature where the sample is
exposed to the ionizing gas stream has been measured
and calculated to be lower [24]. To verify the effect of
temperature, three randomly chosen signals with dif-
ferent m/z values spanning the observed mass range
were selected. A plot of their S/N versus temperature is
shown in Figure 2c, showing that the optimum temper-
ature falls in the range of 150–200 °C depending on the
m/z of these metabolites. High gas temperatures accel-
erate sample drying and analyte thermal desorption
rates, thus increasing the sensitivity of detection, but
too high temperature (250 °C) causes metabolites to
desorb too quickly, resulting in signal loss if the spectral
acquisition rate is not high enough, as would be the case
with a scanning mass analyzer. High gas temperatures
also lead to partial sample charring on the glass capil-
lary surface, leading to irreversible sample degradation.
Helium flow rates were also observed to have a
strong influence on the observed DART-TOF spectra
(Figure 3). The number of metabolites detected in-
creased with increased flow rate, but high gas flow (3 L
min1) dispersed sample particles and remaining sol-
vent directly onto the mass spectrometer inlet, thus
contaminating the inlet orifice. Moreover, high flow gas
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served to affect the reproducibility of the experiments.
The S/N plots for the ionic signals previously studied
indicated an optimum helium flow rate between 2.5 and
3.0 L min1 (Figure 3c).
Time-Dependence of Metabolite
Desorption/Ionization
Although the underlying mechanisms prevailing in the
DART desorption process are complex and beyond the
scope of this study, the observed temporal profiles
following exposure of the derivatized serum sample to
the ionizing gas stream suggest a differential thermal
desorption mechanism for most species observed dur-
ing the first 5 s following switching of the position of
the sampling arm. DART-TOF mass spectra averaged
every 1 s of the total ion chronogram (TIC, solid curve
in Figure 4a) are shown in Figure 4b(a–h). At early times
[Figure 4b(a)], only a few intense signals were detected,
corresponding mostly to light ions. Examination of the
mass spectra obtained between 40 and 44 s [Figure
4b(b–e)], showed that these low mass signals decreased
in intensity with increasing time until they completely
disappeared after 42 s [Figure 4b(d)]. For spectra col-
lected between 42 and 44 s, a large quantity of signals
with medium intensities at masses between m/z 150 and
800 were observed, followed by an overall decay in
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Figure 3. Helium gas flow rate effect on DA
derivatized serum. (a) Mass spectra obtained at
found by matching to HMDB database at differe
spectrometric signals at m/z 205.12, 467.22, andsignal intensity at the trailing edge of the transient TICsignal. Following these experiments, we determined an
optimum time interval for spectrum averaging that
spans regions “c” through “e” in the TIC. However, it
must be noted that this interval will vary depending
on the type of sample holder used, mass range of
the metabolites of interest, and helium flow rate and
temperature.
Repeatability
Highly repeatable measurements are critical in serum
metabolomic fingerprinting since potential biomarkers
of stress or disease are down-selected based on signifi-
cance tests or multivariate analysis of intensity informa-
tion directly obtained from mass spectra. Repeatability
experiments based on 10 separate runs of a control
serum sample are presented in Figure 4c and d. A
coefficient of variation (CV) of 4.5% was obtained for
the TIC peak heights shown in Figure 4c. Relative signal
intensities showed good reproducibility across all spec-
tra (Figure 4d), with an average CV of 18.9% and 16.7%
for the two peaks marked with asterisks, respectively.
Comparison of Metabolic Fingerprints Obtained
by DART-TOF and DART-Q-TOF MS
Experiments similar to those described above for
DART-TOF MS were repeated with a Q-TOF MS instru-
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differentially pumped region is normally achieved with
a heated capillary interface, rather than a small-diameter
orifice as with the TOF mass spectrometer previously
used. For efficient ion transmission into this region, a
gas–ion separator tube (GIST) interface stage was
added between the DART ion source outlet and the
mass spectrometer. The additional pumping incorpo-
rated by this interface also serves the purpose of pre-
venting overload of the mass spectrometer’s vacuum
system. Optimization experiments similar to those de-
scribed above for the DART-TOF MS platform indi-
cated an optimum temperature of 200 °C and an opti-
mum flow rate of 0.55 L min1. This flow rate was the
minimum compatible with maintaining the TOF mass
analyzer within the typical operational values recom-
mended by the manufacturer (1  107 Torr). Com-
pared with the TOF TICs (Figure 4a, solid curve), TICs
observed for DART-Q-TOF MS were much broader
(Figure 4a, dotted curve) due to the lower flow rate of
helium gas used (0.55 L min1) and dispersion effects
caused by the additional VAPUR interface chamber.
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Figure 4. (a) Total ion chronogram (TIC) obser
curve: Q-TOF). Each time segment denotes a tim
mass spectra corresponding to each time inte
injections of a healthy serum sample analyzed b
TIC peaks shown in (c). Asterisks denote signalCompared in terms of absolute signal, the Q-TOF TICfor derivatized serumwas less intense, possibly because
of the much longer distance between the sample and the
MS inlet (3 mm for TOF, 55 mm for Q-TOF). However,
the results for underivatized serum showed that signal-
to-noise ratios for Q-TOF were much better (Figure 5a)
than for TOF, and that the mass range detected reached
m/z 500 even for underivatized serum samples. Table
S-2 lists the tentative identities of peaks observed in
derivatized serum (Figure 5b) with relative intensity
greater than 5% of the base peak. A total of 44 metab-
olites were identified, 25 of them with mass accuracy
better than 1.5 ppm. Only six metabolites were detected
with mass accuracy in this range by TOF MS. DART-
TOF and Q-TOF mass spectra of derivatized serum
were quite different in overall appearance, equivalent to
different “metabolic fingerprints”. Clearly, these finger-
prints should not be compared across different instru-
mental platforms, and multivariate modeling should be
based only on mass spectra obtained under identical
conditions using a single instrument. The repeatability
observed for derivatized human serum analysis by
DART-Q-TOF MS was slightly better than for TOF-MS
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74 ZHOU ET AL. J Am Soc Mass Spectrom 2010, 21, 68–75and an average CV of 13.9% for m/z 315.10 (Supplemen-
tary Information Figure S-1,). This improved repeatabil-
ity is possibly due to the use of the VAPUR® interface
which mitigates uncontrolled turbulence in the ioniza-
tion region.
Conclusions
The rapid DARTMSmethod described in this study has
shown to be an efficient and sensitive approach to
detect metabolites in serum. Its main attractive features
include its high sample throughput, lack of cross-
contamination between runs, and simplicity. The cou-
pling of DART to accurate mass TOF mass spectrome-
ters enables rapid monitoring of the ionic signals and
tentative identification of metabolites. Further develop-
ments in automated DART spectral mining enabling
batch metabolite database queries based on accurate
mass, isotopic profile abundances, and accurate mass
MS/MS data should further benefit this approach.
Application of this method to probing changes in the
human metabolome induced by disease, stress, or other
abnormal conditions will provide a better perspective
on the amount of biological information that may be
Figure 5. DART-Q-TOF mass spectra of he
nonderivatized serum sample, (b) derivatized
(identity of ions follows number between parent
(d) derivatized serum sample spiked with stand
(b) are given in Table S-2.derived from DART MS metabolomic profiles.Acknowledgments
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